Request for Covid-19 Impact Assessment of this Report
The United States Furosemide Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Furosemide Injection market, reaching US$ million by the year 2028. As for the Europe Furosemide Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Furosemide Injection players cover AuroMedics, Baxter, Fresenius Kabi, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Furosemide Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
20mg/2ml
40mg/40ml
100mg/10ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinics
Recovery Center
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AuroMedics
Baxter
Fresenius Kabi
Pfizer
Avet Pharmaceuticals
SteriMax
Hunan Kelun Pharmaceutical
Hainan Huanglong Pharm
Shenyang Guagnda Pharm
Shagnhai Harvest Pharamceutical
Chengdu Brilliant Pharmaceutical
Changbaishan Pharmaceutical
CSPC Ouyi Pharm
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Furosemide Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Furosemide Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Furosemide Injection by Country/Region, 2017, 2022 & 2028
2.2 Furosemide Injection Segment by Type
2.2.1 20mg/2ml
2.2.2 40mg/40ml
2.2.3 100mg/10ml
2.3 Furosemide Injection Sales by Type
2.3.1 Global Furosemide Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Furosemide Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Furosemide Injection Sale Price by Type (2017-2022)
2.4 Furosemide Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Recovery Center
2.5 Furosemide Injection Sales by Application
2.5.1 Global Furosemide Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Furosemide Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Furosemide Injection Sale Price by Application (2017-2022)
3 Global Furosemide Injection by Company
3.1 Global Furosemide Injection Breakdown Data by Company
3.1.1 Global Furosemide Injection Annual Sales by Company (2020-2022)
3.1.2 Global Furosemide Injection Sales Market Share by Company (2020-2022)
3.2 Global Furosemide Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Furosemide Injection Revenue by Company (2020-2022)
3.2.2 Global Furosemide Injection Revenue Market Share by Company (2020-2022)
3.3 Global Furosemide Injection Sale Price by Company
3.4 Key Manufacturers Furosemide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Furosemide Injection Product Location Distribution
3.4.2 Players Furosemide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Furosemide Injection by Geographic Region
4.1 World Historic Furosemide Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Furosemide Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Furosemide Injection Annual Revenue by Geographic Region
4.2 World Historic Furosemide Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Furosemide Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Furosemide Injection Annual Revenue by Country/Region
4.3 Americas Furosemide Injection Sales Growth
4.4 APAC Furosemide Injection Sales Growth
4.5 Europe Furosemide Injection Sales Growth
4.6 Middle East & Africa Furosemide Injection Sales Growth
5 Americas
5.1 Americas Furosemide Injection Sales by Country
5.1.1 Americas Furosemide Injection Sales by Country (2017-2022)
5.1.2 Americas Furosemide Injection Revenue by Country (2017-2022)
5.2 Americas Furosemide Injection Sales by Type
5.3 Americas Furosemide Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Furosemide Injection Sales by Region
6.1.1 APAC Furosemide Injection Sales by Region (2017-2022)
6.1.2 APAC Furosemide Injection Revenue by Region (2017-2022)
6.2 APAC Furosemide Injection Sales by Type
6.3 APAC Furosemide Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Furosemide Injection by Country
7.1.1 Europe Furosemide Injection Sales by Country (2017-2022)
7.1.2 Europe Furosemide Injection Revenue by Country (2017-2022)
7.2 Europe Furosemide Injection Sales by Type
7.3 Europe Furosemide Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Furosemide Injection by Country
8.1.1 Middle East & Africa Furosemide Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Furosemide Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Furosemide Injection Sales by Type
8.3 Middle East & Africa Furosemide Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Furosemide Injection
10.3 Manufacturing Process Analysis of Furosemide Injection
10.4 Industry Chain Structure of Furosemide Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Furosemide Injection Distributors
11.3 Furosemide Injection Customer
12 World Forecast Review for Furosemide Injection by Geographic Region
12.1 Global Furosemide Injection Market Size Forecast by Region
12.1.1 Global Furosemide Injection Forecast by Region (2023-2028)
12.1.2 Global Furosemide Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Furosemide Injection Forecast by Type
12.7 Global Furosemide Injection Forecast by Application
13 Key Players Analysis
13.1 AuroMedics
13.1.1 AuroMedics Company Information
13.1.2 AuroMedics Furosemide Injection Product Offered
13.1.3 AuroMedics Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AuroMedics Main Business Overview
13.1.5 AuroMedics Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Furosemide Injection Product Offered
13.2.3 Baxter Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Furosemide Injection Product Offered
13.3.3 Fresenius Kabi Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Furosemide Injection Product Offered
13.4.3 Pfizer Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Avet Pharmaceuticals
13.5.1 Avet Pharmaceuticals Company Information
13.5.2 Avet Pharmaceuticals Furosemide Injection Product Offered
13.5.3 Avet Pharmaceuticals Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Avet Pharmaceuticals Main Business Overview
13.5.5 Avet Pharmaceuticals Latest Developments
13.6 SteriMax
13.6.1 SteriMax Company Information
13.6.2 SteriMax Furosemide Injection Product Offered
13.6.3 SteriMax Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 SteriMax Main Business Overview
13.6.5 SteriMax Latest Developments
13.7 Hunan Kelun Pharmaceutical
13.7.1 Hunan Kelun Pharmaceutical Company Information
13.7.2 Hunan Kelun Pharmaceutical Furosemide Injection Product Offered
13.7.3 Hunan Kelun Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hunan Kelun Pharmaceutical Main Business Overview
13.7.5 Hunan Kelun Pharmaceutical Latest Developments
13.8 Hainan Huanglong Pharm
13.8.1 Hainan Huanglong Pharm Company Information
13.8.2 Hainan Huanglong Pharm Furosemide Injection Product Offered
13.8.3 Hainan Huanglong Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hainan Huanglong Pharm Main Business Overview
13.8.5 Hainan Huanglong Pharm Latest Developments
13.9 Shenyang Guagnda Pharm
13.9.1 Shenyang Guagnda Pharm Company Information
13.9.2 Shenyang Guagnda Pharm Furosemide Injection Product Offered
13.9.3 Shenyang Guagnda Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shenyang Guagnda Pharm Main Business Overview
13.9.5 Shenyang Guagnda Pharm Latest Developments
13.10 Shagnhai Harvest Pharamceutical
13.10.1 Shagnhai Harvest Pharamceutical Company Information
13.10.2 Shagnhai Harvest Pharamceutical Furosemide Injection Product Offered
13.10.3 Shagnhai Harvest Pharamceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shagnhai Harvest Pharamceutical Main Business Overview
13.10.5 Shagnhai Harvest Pharamceutical Latest Developments
13.11 Chengdu Brilliant Pharmaceutical
13.11.1 Chengdu Brilliant Pharmaceutical Company Information
13.11.2 Chengdu Brilliant Pharmaceutical Furosemide Injection Product Offered
13.11.3 Chengdu Brilliant Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Chengdu Brilliant Pharmaceutical Main Business Overview
13.11.5 Chengdu Brilliant Pharmaceutical Latest Developments
13.12 Changbaishan Pharmaceutical
13.12.1 Changbaishan Pharmaceutical Company Information
13.12.2 Changbaishan Pharmaceutical Furosemide Injection Product Offered
13.12.3 Changbaishan Pharmaceutical Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Changbaishan Pharmaceutical Main Business Overview
13.12.5 Changbaishan Pharmaceutical Latest Developments
13.13 CSPC Ouyi Pharm
13.13.1 CSPC Ouyi Pharm Company Information
13.13.2 CSPC Ouyi Pharm Furosemide Injection Product Offered
13.13.3 CSPC Ouyi Pharm Furosemide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 CSPC Ouyi Pharm Main Business Overview
13.13.5 CSPC Ouyi Pharm Latest Developments
14 Research Findings and Conclusion
Table 1. Furosemide Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Furosemide Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 20mg/2ml
Table 4. Major Players of 40mg/40ml
Table 5. Major Players of 100mg/10ml
Table 6. Global Furosemide Injection Sales by Type (2017-2022) & (K Units)
Table 7. Global Furosemide Injection Sales Market Share by Type (2017-2022)
Table 8. Global Furosemide Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Furosemide Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Furosemide Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Furosemide Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Furosemide Injection Sales Market Share by Application (2017-2022)
Table 13. Global Furosemide Injection Revenue by Application (2017-2022)
Table 14. Global Furosemide Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Furosemide Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Furosemide Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Furosemide Injection Sales Market Share by Company (2020-2022)
Table 18. Global Furosemide Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Furosemide Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Furosemide Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Furosemide Injection Producing Area Distribution and Sales Area
Table 22. Players Furosemide Injection Products Offered
Table 23. Furosemide Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Furosemide Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Furosemide Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Furosemide Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Furosemide Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Furosemide Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Furosemide Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Furosemide Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Furosemide Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Furosemide Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Furosemide Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Furosemide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Furosemide Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Furosemide Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Furosemide Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Furosemide Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Furosemide Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Furosemide Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Furosemide Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Furosemide Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Furosemide Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Furosemide Injection Sales by Type (2017-2022) & (K Units)
Table 47. APAC Furosemide Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Furosemide Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Furosemide Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Furosemide Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Furosemide Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Furosemide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Furosemide Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Furosemide Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Furosemide Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Furosemide Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Furosemide Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Furosemide Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Furosemide Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Furosemide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Furosemide Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Furosemide Injection Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Furosemide Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Furosemide Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Furosemide Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Furosemide Injection
Table 67. Key Market Challenges & Risks of Furosemide Injection
Table 68. Key Industry Trends of Furosemide Injection
Table 69. Furosemide Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Furosemide Injection Distributors List
Table 72. Furosemide Injection Customer List
Table 73. Global Furosemide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Furosemide Injection Sales Market Forecast by Region
Table 75. Global Furosemide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Furosemide Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Furosemide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Furosemide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Furosemide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Furosemide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Furosemide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Furosemide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Furosemide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Furosemide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Furosemide Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Furosemide Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Furosemide Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Furosemide Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Furosemide Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Furosemide Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Furosemide Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Furosemide Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. AuroMedics Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. AuroMedics Furosemide Injection Product Offered
Table 95. AuroMedics Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. AuroMedics Main Business
Table 97. AuroMedics Latest Developments
Table 98. Baxter Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Baxter Furosemide Injection Product Offered
Table 100. Baxter Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Baxter Main Business
Table 102. Baxter Latest Developments
Table 103. Fresenius Kabi Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Fresenius Kabi Furosemide Injection Product Offered
Table 105. Fresenius Kabi Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Fresenius Kabi Main Business
Table 107. Fresenius Kabi Latest Developments
Table 108. Pfizer Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Furosemide Injection Product Offered
Table 110. Pfizer Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Avet Pharmaceuticals Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Avet Pharmaceuticals Furosemide Injection Product Offered
Table 115. Avet Pharmaceuticals Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Avet Pharmaceuticals Main Business
Table 117. Avet Pharmaceuticals Latest Developments
Table 118. SteriMax Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. SteriMax Furosemide Injection Product Offered
Table 120. SteriMax Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. SteriMax Main Business
Table 122. SteriMax Latest Developments
Table 123. Hunan Kelun Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Hunan Kelun Pharmaceutical Furosemide Injection Product Offered
Table 125. Hunan Kelun Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Hunan Kelun Pharmaceutical Main Business
Table 127. Hunan Kelun Pharmaceutical Latest Developments
Table 128. Hainan Huanglong Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Hainan Huanglong Pharm Furosemide Injection Product Offered
Table 130. Hainan Huanglong Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Hainan Huanglong Pharm Main Business
Table 132. Hainan Huanglong Pharm Latest Developments
Table 133. Shenyang Guagnda Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Shenyang Guagnda Pharm Furosemide Injection Product Offered
Table 135. Shenyang Guagnda Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Shenyang Guagnda Pharm Main Business
Table 137. Shenyang Guagnda Pharm Latest Developments
Table 138. Shagnhai Harvest Pharamceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Shagnhai Harvest Pharamceutical Furosemide Injection Product Offered
Table 140. Shagnhai Harvest Pharamceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Shagnhai Harvest Pharamceutical Main Business
Table 142. Shagnhai Harvest Pharamceutical Latest Developments
Table 143. Chengdu Brilliant Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Chengdu Brilliant Pharmaceutical Furosemide Injection Product Offered
Table 145. Chengdu Brilliant Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Chengdu Brilliant Pharmaceutical Main Business
Table 147. Chengdu Brilliant Pharmaceutical Latest Developments
Table 148. Changbaishan Pharmaceutical Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Changbaishan Pharmaceutical Furosemide Injection Product Offered
Table 150. Changbaishan Pharmaceutical Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Changbaishan Pharmaceutical Main Business
Table 152. Changbaishan Pharmaceutical Latest Developments
Table 153. CSPC Ouyi Pharm Basic Information, Furosemide Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. CSPC Ouyi Pharm Furosemide Injection Product Offered
Table 155. CSPC Ouyi Pharm Furosemide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. CSPC Ouyi Pharm Main Business
Table 157. CSPC Ouyi Pharm Latest Developments
List of Figures
Figure 1. Picture of Furosemide Injection
Figure 2. Furosemide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Furosemide Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Furosemide Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Furosemide Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 20mg/2ml
Figure 10. Product Picture of 40mg/40ml
Figure 11. Product Picture of 100mg/10ml
Figure 12. Global Furosemide Injection Sales Market Share by Type in 2021
Figure 13. Global Furosemide Injection Revenue Market Share by Type (2017-2022)
Figure 14. Furosemide Injection Consumed in Hospital
Figure 15. Global Furosemide Injection Market: Hospital (2017-2022) & (K Units)
Figure 16. Furosemide Injection Consumed in Clinics
Figure 17. Global Furosemide Injection Market: Clinics (2017-2022) & (K Units)
Figure 18. Furosemide Injection Consumed in Recovery Center
Figure 19. Global Furosemide Injection Market: Recovery Center (2017-2022) & (K Units)
Figure 20. Global Furosemide Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Furosemide Injection Revenue Market Share by Application in 2021
Figure 22. Furosemide Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Furosemide Injection Revenue Market Share by Company in 2021
Figure 24. Global Furosemide Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Furosemide Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Furosemide Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Furosemide Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Furosemide Injection Sales 2017-2022 (K Units)
Figure 29. Americas Furosemide Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Furosemide Injection Sales 2017-2022 (K Units)
Figure 31. APAC Furosemide Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Furosemide Injection Sales 2017-2022 (K Units)
Figure 33. Europe Furosemide Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Furosemide Injection Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Furosemide Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Furosemide Injection Sales Market Share by Country in 2021
Figure 37. Americas Furosemide Injection Revenue Market Share by Country in 2021
Figure 38. United States Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Furosemide Injection Sales Market Share by Region in 2021
Figure 43. APAC Furosemide Injection Revenue Market Share by Regions in 2021
Figure 44. China Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Furosemide Injection Sales Market Share by Country in 2021
Figure 51. Europe Furosemide Injection Revenue Market Share by Country in 2021
Figure 52. Germany Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Furosemide Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Furosemide Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Furosemide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Furosemide Injection in 2021
Figure 65. Manufacturing Process Analysis of Furosemide Injection
Figure 66. Industry Chain Structure of Furosemide Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...